Pharmacy Learning Network—Patient Case Vignettes: Focus on Multiple Myeloma

On-Demand Case Vignettes

Sponsored by North American Center for Continuing Medical Education, LLC

Faculty

Christopher A. Fausel, PharmD, BCPS, BCOP
Clinical Director, Oncology Pharmacy Services
Hematology/Oncology Section, Department of Medicine
Indiana University Simon Cancer Center
Indianapolis, Indiana

Learning Objectives

After completing this activity, participants should be able to:

• Describe the disease prevalence, clinical and cost burden, and current standards of care for patients with multiple myeloma
• Outline the benefits and limitations of current and emerging therapies for front-line and refractory management of multiple myeloma
• Apply updated National Comprehensive Cancer Network guidelines for frontline and refractory therapy to assist in optimizing outcomes in multiple myeloma

Independent Clinical Reviewer: Sachin Shah, PharmD, BCOP, Associate Professor of Pharmacy Practice, Hematology/Oncology Clinical Pharmacist, Texas Tech University Health Sciences Center - School of Pharmacy, VA North Texas Health Care System, Dallas, Texas

Target Audience

This activity is designed for health-system pharmacists.

Activity Overview

This on-demand case vignette series consists of 2 patient case studies, with polling questions integrated throughout each case.

To be eligible for documentation of credit, participants must review each case study, answer all polling questions, and complete the evaluation form. After successful completion of the evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release Date: December 28, 2009

Expiration Date: December 28, 2010

Estimated time to complete: 30 minutes

There is no fee associated with this activity.

This educational activity is a knowledge-based activity.

For questions regarding this activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for .75 contact hours (0.075 CEU) of continuing pharmacy education (UAN 276-000-09-043-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

Planning Committee

The planning committee comprises Christopher A. Fausel, PharmD, BCPS, BCOP, Sachin Shah, PharmD, BCOP; Kristin Dickie, Mary Johnson, Michael Kearney, Rich Keenan, Nick Lombardi, Erin Phelps, Randy Robbin, John Savage, and Jessica Steuerman, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Fausel: Consultant—Bayer Pharmaceuticals; Promotional speakers bureau—Amgen Pharmaceuticals
Dr. Shah: Advisory board—Celgene

Ms. Dickie, Ms. Johnson, Mr. Kearney, Mr. Keenan, Mr. Lombardi, Ms. Phelps, Mr. Robbin, Mr. Savage, and Ms. Steuerman have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Millennium Pharmaceuticals, Inc